References

Butler SM, Boucher EA, Tobison Phan H. Medication Use in Schools: Current Trends, Challenges, and Best Practices. J Pediatr Pharmacol Ther. 2020; 25:(1)7-24 https://doi.org/10.5863/1551-6776-25.1.7

Jones BL. Pharmacokinetics in children. MSD Manual: Professional version, Merck.2022

Kwok PC, Chan H. Delivery of inhalation drugs to children for asthma and other respiratory diseases. Adv Drug Deliv Rev. 2014; 73:83-8 https://doi.org/10.1016/j.addr.2013.11.007

Linakis MW, Roberts JK, Lala AC Challenges Associated with Route of Administration in Neonatal Drug Delivery. Clin Pharmacokinet. 2016; 55:(2)185-196 https://doi.org/10.1007/s40262-015-0313-z

Lu H, Rosenbaum S. Developmental pharmacokinetics in pediatric populations. J Pediatr Pharmacol Ther. 2014; 19:(4)262-76 https://doi.org/10.5863/1551-6776-19.4.262

Mason KP, Lerman J. Review article: Dexmedetomidine in children: current knowledge and future applications. Anesth Analg. 2011; 113:(5)1129-42 https://doi.org/10.1213/ANE.0b013e31822b8629

Mayel M, Nejad N, Khabaz MS, Bazrafshani MS, Mohajeri E. Intranasal midazolam sedation as an effective sedation route in pediatric patients for radiologic imaging in the emergency ward: A single-blind randomized trial. Turk J Emerg Med. 2020; 20:(4)168-174 https://doi.org/10.4103/2452-2473.297461

O'Hara K. Paediatric pharmacokinetics and drug doses. Aust Prescr. 2016; 39:(6)208-210

Pansini VA, Curatola A, Gatto I, Lazzareschi A, Ruggiero A, Chiaretti A. Intranasal drugs for analgesia and sedation in children admitted to pediatric emergency department: a narrative review. Ann Transl Med. 2021; 9:(2) https://doi.org/10.21037/atm-20-5177

Sage DP, Kulczar C, Roth W, Liu W, Knipp G. Persistent pharmacokinetic challenges to pediatric drug development. Front Genet. 2014; 27:(5) https://doi.org/10.3389/fgene.2014.00281

Paediatric Pharmacology. 2008. https://resources.wfsahq.org/atotw/paediatric-pharmacology (accessed 22 August 2023)

When to use intranasal medications in children. 2015. https://www.acepnow.com/article/when-to-use-intranasal-medications-in-children (accessed 22 August 2023)

van den Anker J, Reed MD, Allegaert K, Kearns GL. Developmental Changes in Pharmacokinetics and Pharmacodynamics. J Clin Pharmacol. 2018; 58:S10-S25 https://doi.org/10.1002/jcph.128

A–Z of prescribing for children

02 September 2023
Volume 5 · Issue 9

Abstract

This series focuses on aspects of prescribing for neonates, children and young people, from A–Z. Aspects of pharmacokinetics will be considered, alongside legal considerations, consent and medications in schools

It is commonly stated that children are not just small adults; yet, most paediatric medication doses are still calculated from studies in adults (O'Hara, 2016). A knowledge of physiological differences between children and adults is imperative to have a thorough understanding in differences in pharmacokinetics.

Unless administered intravenously, drugs need to cross semipermeable cell membranes before they finally reach the systemic circulation. There are many other ways in which drugs are administered by extravascular routes, such as via the gastrointestinal (GI) tract, topical or transdermal, and through the lungs being the most common routes (van den Anker et al, 2018). Most drugs in children are administered orally. The taste of medications is an important factor (see ‘T’ later in this series), as children will naturally reject bitter or foul-tasting medications. However, once successfully taken, drugs will enter the stomach and gastric pH needs to be considered (Figure 1).

Register now to continue reading

Thank you for visiting Journal of Prescribing Practice and reading some of our peer-reviewed resources for prescribing professionals. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • New content and clinical newsletter updates each month